BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gu Q, Bowden GT, Normolle D, Sun Y. SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB. J Cell Biol. 2007;178:1009-1023. [PMID: 17846172 DOI: 10.1083/jcb.200612067] [Cited by in Crossref: 30] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Xiao Y, Jiang Y, Song H, Liang T, Li Y, Yan D, Fu Q, Li Z. RNF7 knockdown inhibits prostate cancer tumorigenesis by inactivation of ERK1/2 pathway. Sci Rep 2017;7:43683. [PMID: 28252001 DOI: 10.1038/srep43683] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
2 Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, Shelton MD. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal 2008;10:1941-88. [PMID: 18774901 DOI: 10.1089/ars.2008.2089] [Cited by in Crossref: 401] [Cited by in F6Publishing: 386] [Article Influence: 30.8] [Reference Citation Analysis]
3 Li D, Lin Y, Liu Z, Zhang Y, Rong Z, Liu X. Transcriptional regulation of human novel gene SPATA12 promoter by AP-1 and HSF. Gene 2012;511:18-25. [PMID: 22981541 DOI: 10.1016/j.gene.2012.08.047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Ouyang W, Guo P, Takeda K, Fu Q, Fang H, Frucht DM. Erk1/2 inactivation promotes a rapid redistribution of COP1 and degradation of COP1 substrates. Proc Natl Acad Sci U S A 2020;117:4078-87. [PMID: 32041890 DOI: 10.1073/pnas.1913698117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Xie CM, Wei D, Zhao L, Marchetto S, Mei L, Borg JP, Sun Y. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis. J Cell Biol 2015;209:721-37. [PMID: 26056141 DOI: 10.1083/jcb.201411104] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
6 Snoek BC, Wilt LH, Jansen G, Peters GJ. Role of E3 ubiquitin ligases in lung cancer. World J Clin Oncol 2013; 4(3): 58-69 [PMID: 23936758 DOI: 10.5306/wjco.v4.i3.58] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zhao Y, Sun Y. Cullin-RING Ligases as attractive anti-cancer targets. Curr Pharm Des 2013;19:3215-25. [PMID: 23151137 DOI: 10.2174/13816128113199990300] [Cited by in Crossref: 149] [Cited by in F6Publishing: 148] [Article Influence: 18.6] [Reference Citation Analysis]
8 Tan M, Li H, Sun Y. Inactivation of Sag/Rbx2/Roc2 e3 ubiquitin ligase triggers senescence and inhibits kras-induced immortalization. Neoplasia 2015;17:114-23. [PMID: 25622904 DOI: 10.1016/j.neo.2014.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zhao Y, Xiong X, Sun Y. DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy. Mol Cell 2011;44:304-16. [PMID: 22017876 DOI: 10.1016/j.molcel.2011.08.029] [Cited by in Crossref: 183] [Cited by in F6Publishing: 179] [Article Influence: 18.3] [Reference Citation Analysis]
10 Tan M, Li Y, Yang R, Xi N, Sun Y. Inactivation of SAG E3 ubiquitin ligase blocks embryonic stem cell differentiation and sensitizes leukemia cells to retinoid acid. PLoS One 2011;6:e27726. [PMID: 22110742 DOI: 10.1371/journal.pone.0027726] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
11 Tan M, Xu J, Siddiqui J, Feng F, Sun Y. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis. Mol Cancer 2016;15:81. [PMID: 27955654 DOI: 10.1186/s12943-016-0567-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
12 Wang H, Fu C, Du J, Wang H, He R, Yin X, Li H, Li X, Li K, Zheng L, Liu Z, Qiu Y. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells. J Exp Clin Cancer Res. 2020;39:29. [PMID: 32024543 DOI: 10.1186/s13046-020-1536-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
13 Xie CM, Wei W, Sun Y. Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer. J Genet Genomics 2013;40:97-106. [PMID: 23522382 DOI: 10.1016/j.jgg.2013.02.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
14 Tan M, Li H, Sun Y. Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis. Oncogene 2014;33:5211-20. [PMID: 24213570 DOI: 10.1038/onc.2013.473] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
15 Liu A, Zhang S, Li W, Xu B, Lei R, Zhu S. SAG expression associates with COPB2-related signaling and a poorer prognosis in breast cancer. Aging (Albany NY) 2020;12:902-11. [PMID: 31926110 DOI: 10.18632/aging.102663] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhao Y, Xiong X, Sun Y. Cullin-RING Ligase 5: Functional characterization and its role in human cancers. Semin Cancer Biol 2020;67:61-79. [PMID: 32334051 DOI: 10.1016/j.semcancer.2020.04.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
17 Bode AM, Dong Z. Signal transduction molecules as targets for cancer prevention. Sci Signal 2009;2:mr2. [PMID: 19244209 DOI: 10.1126/scisignal.259mr2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
18 Xie CM, Tan M, Lin XT, Wu D, Jiang Y, Tan Y, Li H, Ma Y, Xiong X, Sun Y. The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways. Cell Rep 2019;26:3037-3050.e4. [PMID: 30865892 DOI: 10.1016/j.celrep.2019.02.052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
19 Jia L, Sun Y. SCF E3 ubiquitin ligases as anticancer targets. Curr Cancer Drug Targets 2011;11:347-56. [PMID: 21247385 DOI: 10.2174/156800911794519734] [Cited by in Crossref: 96] [Cited by in F6Publishing: 87] [Article Influence: 9.6] [Reference Citation Analysis]
20 Tan M, Zhao Y, Kim SJ, Liu M, Jia L, Saunders TL, Zhu Y, Sun Y. SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation. Dev Cell. 2011;21:1062-1076. [PMID: 22118770 DOI: 10.1016/j.devcel.2011.09.014] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
21 Zhou MJ, Chen FZ, Chen HC. Ubiquitination involved enzymes and cancer. Med Oncol 2014;31:93. [PMID: 25023052 DOI: 10.1007/s12032-014-0093-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
22 Li L, Yang H, He Y, Li T, Feng J, Chen W, Ao L, Shi X, Lin Y, Liu H, Zheng E, Lin Q, Bu J, Zeng Y, Zheng M, Xu Y, Liao Z, Lin J, Lin D. Ubiquitin-Specific Protease USP6 Regulates the Stability of the c-Jun Protein. Mol Cell Biol 2018;38:e00320-17. [PMID: 29061731 DOI: 10.1128/MCB.00320-17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
23 Huang X, Chen J, Cao W, Yang L, Chen Q, He J, Yi Q, Huang H, Zhang E, Cai Z. The many substrates and functions of NEDD4-1. Cell Death Dis 2019;10:904. [PMID: 31787758 DOI: 10.1038/s41419-019-2142-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
24 Zhou W, Wei W, Sun Y. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases. Cell Res 2013;23:599-619. [PMID: 23528706 DOI: 10.1038/cr.2013.44] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
25 Shao J, Teng Y, Padia R, Hong S, Noh H, Xie X, Mumm JS, Dong Z, Ding HF, Cowell J, Kim J, Han J, Huang S. COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis. Neoplasia 2013;15:1075-85. [PMID: 24027432 DOI: 10.1593/neo.13966] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
26 Ozden SA, Ozyurt H, Ozgen Z, Kilinc O, Oncel M, Gul AE, Karadayi N, Serakinci N, Kan B, Orun O. Prognostic role of sensitive-to-apoptosis gene expression in rectal cancer. World J Gastroenterol 2011; 17(44): 4905-4910 [PMID: 22171132 DOI: 10.3748/wjg.v17.i44.4905] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
27 Sun Y, Li H. Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase. Protein Cell 2013;4:103-16. [PMID: 23136067 DOI: 10.1007/s13238-012-2105-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
28 Jia L, Yang J, Hao X, Zheng M, He H, Xiong X, Xu L, Sun Y. Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target. Clin Cancer Res. 2010;16:814-824. [PMID: 20103673 DOI: 10.1158/1078-0432.ccr-09-1592] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 5.8] [Reference Citation Analysis]
29 Zhang Q, Wei D, Tan M, Li H, Morgan MA, Sun Y. Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras-PDAC model. Neoplasia 2020;22:242-52. [PMID: 32339950 DOI: 10.1016/j.neo.2020.03.002] [Reference Citation Analysis]
30 Mazière C, Mazière JC. Activation of transcription factors and gene expression by oxidized low-density lipoprotein. Free Radic Biol Med 2009;46:127-37. [PMID: 18996472 DOI: 10.1016/j.freeradbiomed.2008.10.024] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
31 Fenner BJ, Scannell M, Prehn JH. Expanding the substantial interactome of NEMO using protein microarrays. PLoS One 2010;5:e8799. [PMID: 20098747 DOI: 10.1371/journal.pone.0008799] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
32 He H, Gu Q, Zheng M, Normolle D, Sun Y. SAG/ROC2/RBX2 E3 ligase promotes UVB-induced skin hyperplasia, but not skin tumors, by simultaneously targeting c-Jun/AP-1 and p27. Carcinogenesis 2008;29:858-65. [PMID: 18258608 DOI: 10.1093/carcin/bgn021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
33 Tan M, Zhu Y, Kovacev J, Zhao Y, Pan ZQ, Spitz DR, Sun Y. Disruption of Sag/Rbx2/Roc2 induces radiosensitization by increasing ROS levels and blocking NF-kappaB activation in mouse embryonic stem cells. Free Radic Biol Med 2010;49:976-83. [PMID: 20638939 DOI: 10.1016/j.freeradbiomed.2010.05.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
34 Zhou W, Xu J, Zhao Y, Sun Y. SAG/RBX2 is a novel substrate of NEDD4-1 E3 ubiquitin ligase and mediates NEDD4-1 induced chemosensitization. Oncotarget 2014;5:6746-55. [PMID: 25216516 DOI: 10.18632/oncotarget.2246] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
35 Jang SM, Redon CE, Aladjem MI. Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy. Front Mol Biosci 2018;5:19. [PMID: 29594129 DOI: 10.3389/fmolb.2018.00019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
36 Bielskienė K, Bagdonienė L, Mozūraitienė J, Kazbarienė B, Janulionis E. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma. Medicina (Kaunas) 2015;51:1-9. [PMID: 25744769 DOI: 10.1016/j.medici.2015.01.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
37 Wei D, Sun Y. Small RING Finger Proteins RBX1 and RBX2 of SCF E3 Ubiquitin Ligases: The Role in Cancer and as Cancer Targets. Genes Cancer 2010;1:700-7. [PMID: 21103004 DOI: 10.1177/1947601910382776] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
38 Li H, Tan M, Jia L, Wei D, Zhao Y, Chen G, Xu J, Zhao L, Thomas D, Beer DG, Sun Y. Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis. J Clin Invest 2014;124:835-46. [PMID: 24430184 DOI: 10.1172/JCI70297] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
39 Chen Z, Sui J, Zhang F, Zhang C. Cullin family proteins and tumorigenesis: genetic association and molecular mechanisms. J Cancer 2015;6:233-42. [PMID: 25663940 DOI: 10.7150/jca.11076] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]